Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nansha Biologics is a biotechnology company based in Guangzhou, China, specializing in the development and contract manufacturing of biological therapeutics. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing end-to-end services from cell line development and process optimization to large-scale GMP manufacturing. Strategically located in the Nansha district, it leverages advanced single-use bioreactor technologies to support both domestic and international biopharmaceutical clients. Its facilities are designed to meet global regulatory standards, facilitating the production of monoclonal antibodies and other recombinant proteins for clinical trials and commercial supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nansha Biologics.